Text/HTML

We will be performing maintenance on this site on March 24, 2024 starting at 6:00 am until 8:00 am.  We apologize for the inconvenience.  


Mobile App

Google Play Apple Store

EasyDNNNews

Independent Conference Coverage from The American Thoracic Society (ATS) International Conference 2023*
AMA/ANCC/ACPE Activity - Clinical Clips
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in Washington, DC, May 19-24, 2023.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.



Vijay Balasubramanian, MD, MRCP (UK) Vijay Balasubramanian, MD, MRCP (UK)
Section Chair, Pulmonary Vascular Disease Network
American College of Chest Physicians (ACCP)  

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the American Thoracic Society (ATS) International Conference 2023.
20

Supported by independent educational grants from United Therapeutics, a public benefit company; Bayer U.S.; and Actelion Pharmaceuticals U.S., Inc.,

A Janssen Pharmaceutical Company of Johnson & Johnson


Launch Date: May 22, 2023

Release Date: May 22, 2023

Expiration Date: April 30, 2024

April 30, 2024
Mini Module
7563
ClinicalClips_PAH_1150x108.png
Pulmonology